Korea Cancer Center Hospital
25
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
16.0%
4 terminated/withdrawn out of 25 trials
73.3%
-13.2% vs industry average
28%
7 trials in Phase 3/4
9%
1 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (25)
Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Role: collaborator
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Role: collaborator
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Role: lead
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
Role: collaborator
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
Role: lead
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm
Role: lead
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion
Role: lead
Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial
Role: collaborator
Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
Role: lead
Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients
Role: lead
Open Versus Laparoscopic Left-sided Hepatectomy Trial
Role: collaborator
SBRT for Extra-cranial Oligorecurrent Tumor
Role: lead
Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
Role: collaborator
RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas
Role: collaborator
Cohort of Peripheral T Cell Lymphoma
Role: lead
Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)
Role: collaborator
Intraperitoneal Chemotherapy and Systemic Chemotherapy Versus Systemic Chemotherapy After Curative Resection of Serosa-positive Gastric Cancer
Role: collaborator
A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer
Role: lead
Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer
Role: lead
Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer
Role: lead